Study Results: Anika’s HYALOFAST in Knee Cartilage Lesions

Studies indicate that Anika Therapeutics' HYALOFAST® biodegradable HA-based scaffold + autologous adult mesenchymal stem cells (MSCs) is a viable, effective option to treat knee cartilage lesions, regardless of patient age.

Specifically, the data revealed equally effective outcomes in patients both under and over the age of 45. The latter are...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us